AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 88, Issue 8 1239-1242, Copyright © 1998 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinkerton, S D
Right arrow Articles by Kelly, J A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinkerton, S D
Right arrow Articles by Kelly, J A
Cost-effectiveness of a community-level HIV risk reduction intervention.

S D Pinkerton, D R Holtgrave, W J DiFranceisco, L Y Stevenson and J A Kelly

Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee 53226, USA.

OBJECTIVES: The authors evaluated the cost-effectiveness of a community-level HIV prevention intervention that used peer leaders to endorse risk reduction among gay men. METHODS: A mathematical model of HIV transmission was used to translate reported changes in sexual behavior into an estimate of the number of HIV infections averted. RESULTS: The intervention cost $17,150, or about $65,000 per infection averted, and was therefore cost-saving, even under very conservative modeling assumptions. CONCLUSIONS: For this intervention, the cost of HIV prevention was more than offset by savings in averted future medical care costs. Community-level interventions to prevent HIV transmission that use existing social networks can be highly cost-effective.




This article has been cited by other articles:


Home page
J Int Assoc Physicians AIDS Care (Chic Ill)Home page
G. K. Ateka and D. R. Lairson
School-Based HIV/STD Prevention Programs: Do Benefits Justify Costs?
J Int Assoc Physicians AIDS Care (Chic Ill), February 1, 2008; 7(1): 46 - 51.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
J. Hornberger, M. Holodniy, K. Robertus, M. Winnike, E. Gibson, and E. Verhulst
A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy
Med Decis Making, December 1, 2007; 27(6): 789 - 821.
[Abstract] [PDF]


Home page
The ANNALS of the American Academy of Political and Social ScienceHome page
K. J. Sikkema
HIV Prevention among Women in Low-Income Housing Developments: Issues and Intervention Outcomes in a Place-Based Randomized Controlled Trial
The ANNALS of the American Academy of Political and Social Science, May 1, 2005; 599(1): 52 - 70.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton
A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention
Med Decis Making, November 1, 2004; 24(6): 634 - 653.
[Abstract] [PDF]


Home page
JOURNAL OF CORRECTIONAL HEALTH CAREHome page
E. M. Howell, R. B. Greifinger, and A. S. Sommers
What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners?
Journal of Correctional Health Care, April 1, 2004; 10(3): 399 - 436.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
S. D. Pinkerton and D. R. Holtgrave
How HIV Treatment Advances Affect the Cost--Effectiveness of Prevention
Med Decis Making, January 1, 2000; 20(1): 89 - 94.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
S. K. Brodine, R. A. Shaffer, M. J. Starkey, S. A. Tasker, J. L. Gilcrest, M. K. Louder, A. Barile, T. C. VanCott, M. T. Vahey, F. E. McCutchan, et al.
Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion
Ann Intern Med, October 5, 1999; 131(7): 502 - 506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Public Health Association